131 related articles for article (PubMed ID: 22936458)
1. Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus.
Birnbaum Y; Castillo AC; Qian J; Ling S; Ye H; Perez-Polo JR; Bajaj M; Ye Y
Cardiovasc Drugs Ther; 2012 Dec; 26(6):445-56. PubMed ID: 22936458
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
Ye Y; Qian J; Castillo AC; Ling S; Ye H; Perez-Polo JR; Bajaj M; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H131-41. PubMed ID: 23103492
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP and PKA: how can a lot of good come from the potentially bad? : editorial to: "phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus" by Y. Birnbaum et al.
Huisamen B
Cardiovasc Drugs Ther; 2012 Dec; 26(6):435-6. PubMed ID: 23054030
[No Abstract] [Full Text] [Related]
4. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
[TBL] [Abstract][Full Text] [Related]
5. PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
Birnbaum Y; Nanhwan MK; Ling S; Perez-Polo JR; Ye Y; Bajaj M
Cardiovasc Drugs Ther; 2014 Oct; 28(5):447-57. PubMed ID: 25106875
[TBL] [Abstract][Full Text] [Related]
6. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Ye Y; Keyes KT; Zhang C; Perez-Polo JR; Lin Y; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1454-65. PubMed ID: 20207816
[TBL] [Abstract][Full Text] [Related]
7. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
Fukasawa M; Nishida H; Sato T; Miyazaki M; Nakaya H
J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions.
Wada T; Onogi Y; Kimura Y; Nakano T; Fusanobori H; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
Eur J Pharmacol; 2013 May; 707(1-3):120-9. PubMed ID: 23528355
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway.
Chen WJ; Chen YH; Lin KH; Ting CH; Yeh YH
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2106-13. PubMed ID: 21680899
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
Hausenloy DJ; Whittington HJ; Wynne AM; Begum SS; Theodorou L; Riksen N; Mocanu MM; Yellon DM
Cardiovasc Diabetol; 2013 Oct; 12():154. PubMed ID: 24148218
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibition attenuates arrhythmias via a protein kinase A-dependent pathway in infarcted hearts.
Lee TM; Chen WT; Chang NC
Circ J; 2015; 79(11):2461-70. PubMed ID: 26399925
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol promotes production of melanin by activating the microphthalmia-associated transcription factor (MITF).
Wei B; Zhang YP; Yan HZ; Xu Y; Du TM
Biochem Biophys Res Commun; 2014 Jan; 443(2):617-21. PubMed ID: 24333333
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.
Ke K; Safder AM; Sul OJ; Suh JH; Joe Y; Chung HT; Choi HS
PLoS One; 2015; 10(5):e0124869. PubMed ID: 25992691
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol improves hippocampus-dependent long-term memory in mice.
Yanai S; Semba Y; Ito H; Endo S
Psychopharmacology (Berl); 2014 Jul; 231(13):2681-93. PubMed ID: 24464529
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
Ota H; Eto M; Kano MR; Ogawa S; Iijima K; Akishita M; Ouchi Y
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1634-9. PubMed ID: 18556572
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol promotes mitochondrial biogenesis in human umbilical vein endothelial cells through activating the expression of PGC-1α.
Zuo L; Li Q; Sun B; Xu Z; Ge Z
Biochem Biophys Res Commun; 2013 Mar; 433(1):52-7. PubMed ID: 23485471
[TBL] [Abstract][Full Text] [Related]
18. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Hashimoto A; Miyakoda G; Hirose Y; Mori T
Atherosclerosis; 2006 Dec; 189(2):350-7. PubMed ID: 16545819
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
Hashimoto A; Tanaka M; Takeda S; Ito H; Nagano K
PLoS One; 2015; 10(7):e0132835. PubMed ID: 26181635
[TBL] [Abstract][Full Text] [Related]
20. Differences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgery.
Wang B; Raedschelders K; Shravah J; Hui Y; Safaei HG; Chen DD; Cook RC; Fradet G; Au CL; Ansley DM
Clin Endocrinol (Oxf); 2011 Jun; 74(6):705-13. PubMed ID: 21521253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
